A randomized, phase 2 study of R-CHOP plus enzastaurin vs R-CHOP in patients with intermediate- or high-risk diffuse large B-cell lymphoma. Issue 1 (2nd January 2016) - Hainsworth, John D.; Arrowsmith, Edward R.; McCleod, Michael; Hsi, Eric D.; Hamid, Oday; Shi, Peipei; Lin, Boris K.; Fayad, Luis E.